Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433381
Status:
COMPLETED
Last Update Posted:
2018-09-17
First Post:
2007-02-08
Brief Title:
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Adult Brain Neoplasm |
| Adult Glioblastoma |
| Adult Gliosarcoma |
Keywords: